Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 947 across all filing types
Latest filing 2022-09-13 Board/Management Inform…
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Resignation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the resignation of the Chief Financial Officer of Neuland Laboratories Limited. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in key managerial personnel. The content is an announcement of a management change rather than a financial report, audit, or other types of filings. The document length is short and focused solely on the resignation event. Therefore, it fits the category of Board/Management Information (MANG).
2022-09-13 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for Neuland Laboratories Limited for the quarter ended June 30, 2022 (Q1 FY23). It includes management commentary on financial results, business trends, segment performance, and a Q&A session with analysts. The text explicitly mentions it is a transcript of the earnings call conducted on August 3, 2022, and contains detailed financial figures, business segment analysis, and forward-looking statements. This matches the definition of a Call Transcript (CT), which is a full text transcript of company conference calls such as earnings calls with Q&A. The document is not a brief earnings release (ER), nor is it an announcement or presentation. It contains substantive content from the call itself, including management remarks and Q&A, confirming it is a Call Transcript.
2022-08-08 English
Newspaper Advertisements
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding the publication of newspaper advertisements for the unaudited financial results for the quarter ended June 30, 2022. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) and encloses copies of the advertisements. The document itself does not contain the financial results or detailed financial statements but is an announcement about the publication of such results in newspapers. The document length is short (1694 characters), and it serves as a notification rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement related to financial results publication, not the Interim/Quarterly Report (IR) itself.
2022-08-04 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recordings of an earnings call conducted on August 3, 2022, for the quarter ended June 30, 2022. It provides a link to the audio recordings but does not contain the transcript or detailed financial data itself. The document length is short (1704 characters) and serves as an announcement or notification rather than the full earnings call transcript. According to the rules, announcements providing links to reports or recordings without the full content should be classified as Regulatory Filings (RNS) rather than Call Transcript (CT) or Earnings Release (ER).
2022-08-03 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed communication from Neuland Laboratories Limited to stock exchanges (NSE and BSE) dated August 3, 2022. It announces the approval by the Board of Directors of the unaudited standalone and consolidated financial results for the quarter ended June 30, 2022. The document includes financial tables with revenue, expenses, profit before tax, tax expenses, and earnings per share, as well as notes explaining the preparation and review of the financial results. It also mentions the limited review reports by statutory auditors and a press release and presentation to investors/analysts. The presence of comprehensive financial data for a quarter, along with notes and auditor review, indicates this is a quarterly financial report. The document is not merely an announcement of a report but contains substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2022-08-03 English
Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an official communication from Neuland Laboratories Limited addressed to stock exchanges regarding the outcome of the 38th Annual General Meeting (AGM) held on August 2, 2022. It includes a summary of proceedings, voting results, and the Scrutinizer's report as required by SEBI regulations. The content focuses on the AGM event details, resolutions passed, voting statistics, and procedural compliance. There is no detailed financial data or full report content such as an Annual Report or Interim Report. The document is a formal announcement of the AGM outcome and voting results, not the report itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length (15,000 characters) supports it being a detailed announcement rather than a brief notice or a full report.
2022-08-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.